CN102586202A - Thioredoxin and preparation method and application thereof - Google Patents
Thioredoxin and preparation method and application thereof Download PDFInfo
- Publication number
- CN102586202A CN102586202A CN201210066091XA CN201210066091A CN102586202A CN 102586202 A CN102586202 A CN 102586202A CN 201210066091X A CN201210066091X A CN 201210066091XA CN 201210066091 A CN201210066091 A CN 201210066091A CN 102586202 A CN102586202 A CN 102586202A
- Authority
- CN
- China
- Prior art keywords
- trx
- plasmid
- petrx
- transformed
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the field of molecular biology, in particular to Cynoglossus semilaevis thioredoxin and a preparation method and application thereof. The thioredoxin is shown as an amino acid sequence in a sequence table SEQ ID No.1. The preparation method comprises the following steps of: constructing a plasmid pETrx, transforming the plasmid pETrx by using BL21(DE3) to obtain BL21(DE3)/pETrx, inducing by using isopropyl-beta-D-isopropylthiogalactoside, and purifying recombinant protein by using an affinity chromatography column to obtain the thioredoxin. The thioredoxin has remarkable reductase activity, a remarkable antioxidation effect and a remarkable cell growth promotion effect.
Description
Technical field
The present invention relates to biology field, a kind of specifically Cynoglossus semilaevis Trx and preparation and application.
Background technology
(thioredoxin is the small molecules reduction albumen of about 12 kDa of a kind of molecular weight Trx) to Trx, extensively is present in various protokaryons and most eukaryotes.Trx has a catalytic site high conservative, the tool reducing activity, and its constitutional features is CXXC.Trx and the effect of various sulfydryl albumen are two sulfydryls with its disulfide bond reduction.Function whereby, Trx is regulated and control multiple important biomolecule process, like the keeping of redox state, genetic expression, immunoreation etc.The Trx of known higher animal has the various biological activity, comprises anti-oxidant activity, growth promoting function, anti-apoptotic, antitumor action etc.But the research of fish Trx seldom, and its effect and BA are neither very clear.
Summary of the invention
The object of the invention is to provide a kind of Trx and preparation and application.
For realizing above-mentioned purpose, the technical scheme that the present invention adopts is:
A kind of Trx, Trx are shown in the aminoacid sequence among the sequence table SEQ ID No.1.
Said Trx is the recombinant protein that contains the eukaryotic expression recombination plasmid pETrx transformed into escherichia coli DH5 α acquisition of tabulation SEQ ID No.1.
The preparation method of Trx:
With Cynoglossus semilaevis cDNA is template, carries out pcr amplification with primers F 1 with R1, is connected with carrier pBS-T behind the PCR product purification, connects the mixed solution transformed into escherichia coli, gets plasmid pBSTrx;
Above-mentioned plasmid pBSTrx and plasmid pET259 are cut with restriction enzyme EcoRV enzyme, and endonuclease bamhi connects with the T4DNA ligase enzyme, connects liquid and is transformed into intestinal bacteria, gets plasmid pETrx;
Above-mentioned gained plasmid pETrx is transformed BL21 (DE3), and gained transformant BL21 (DE3)/pETrx purifying gained recombinant protein is the Trx shown in the aminoacid sequence among the sequence table SEQ ID No.1;
Said F1 is 5 '-GATATCATGGTTTACGAAGTGAAAG-3 '; R1 is 5 '-GATATCTTCTTTTTCATACTGCTTC-3 '.
The application of Trx, the amino acid sequences encoded Trx among the said sequence table SEQ ID No.1 is as the preparation of reductase activity, anti-oxidant or promoting growth of cell.
The present invention has following advantage: Trx preparation of the present invention is simple, has tangible reductase activity, antioxygenation and promoting growth of cell ability.
Description of drawings
(wherein, the Trx that obtains of purifying is a swimming lane 2 to the Trx electrophoretogram that the purifying that Fig. 1 provides for the embodiment of the invention obtains; Swimming lane 1: molecular weight marker.)。
The reductase activity detection figure of the Trx that Fig. 2 provides for the embodiment of the invention.
Embodiment
Below in conjunction with embodiment the present invention is described further.Embodiment is intended to the description of giving an example to the present invention, but not limits the invention in any form.
Involved in embodiments of the present invention routine property experimental technique all adopts following method:
1. plasmid extraction, DNA (PCR) product purification, dna fragmentation reclaim the corresponding reagent box that all uses " TIANGEN Biotech (Beijing) Co., Ltd. " from gel.
2. intestinal bacteria are with Hanahan method (Sambrook and Russell:Molecular Cloning:A Laboratory Mannual.Cold Spring Harbor Laboratory Press2001); Yeast conversion is pressed the method (Catalog no.V175-20) of Invitrogen company; Polyacrylamide gel electrophoresis (SDS-PAGE) is according to Sambrook and Russell:Molecular Cloning:A Laboratory Mannual.Cold Spring Harbor Laboratory Press2001.
3. all restriction enzymes and ligase enzyme are all available from " Niu Yinglun Bioisystech Co., Ltd ", Beijing.
Trx of the present invention is the aminoacid sequence among the sequence table SEQ ID No.1.Sequence table SEQ ID No.1 is:
MVYEVKDYNDFTQQLKRAGNKLVVVDFTATWCQPCKNISPVFEELANQYKNVVFLKVDVDEADDVSTECE?I?NCMPTFLFYRNEKRVHSFSGANSDTLRAAVKQYEKE
(a) sequence signature:
Length: 107
Type: aminoacid sequence
Chain: strand
Topological framework: linearity
(b) molecule type: protein
(c) suppose: not
(d) antisense: not
(e) initial source: Cynoglossus semilaevis
Constructional feature: this albumen expection contains a CXXC structural domain, and 35-38 constitutes by amino acid,
The preparation method of Trx:
1) structure of plasmid pETrx:
With Cynoglossus semilaevis cDNA is template, carries out pcr amplification with primers F 1 with R1.The PCR condition is: 94 ℃ of preparatory sex change template DNAs of 60s, 94 ℃ of 40s then, 48 ℃ of 60s, 72 ℃ of 60s change 94 ℃ of 40s into after 5 circulations, 58 ℃ of 60s, 72 ℃ of 60s, after 30 circulations again at 72 ℃ of extension 7-10min.Be connected 4-6 hour with carrier pBS-T (purchasing) in room temperature behind the PCR product purification in " TIANGEN Biotech (Beijing) Co., Ltd. "; On the LB substratum that contains peace card penicillium mould (100ug/ml), Xgal (40ug/ml), isopropyl-(24ug/ml), cultivated 18-24 hour after connecting mixed solution transformed into escherichia coli DH5 α; The screening transformant extracts plasmid, is plasmid pBSTrx.(plasmid pET259 building process is referring to Zheng, W.J., Hu with pBSTrx and plasmid pET259; Y.H., Sun, L.; 2010.Cloning and analysis of a ferritin subunit from turbot (Scophthalmus maximus) .Fish.Shellfish.Immunol.28 829-836) cuts the back with restriction enzyme EcoRV enzyme and reclaims 0.3kb and 5.4kb fragment, and this two fragment is connected with the T4DNA ligase enzyme; Connect liquid and be transformed into bacillus coli DH 5 alpha; On the LB substratum that contains kantlex (30ug/ml), cultivated 18-24 hour, the screening transformant extracts plasmid, is pETrx.
Said LB moity is by weight percentage: 1.0% peptone, 0.5% yeast powder, 1.0% sodium-chlor, 97.5% zero(ppm) water.Said F1 is 5 '-GATATCATGGTTTACGAAGTGAAAG-3 '; R1 is 5 '-GATATCTTCTTTTTCATACTGCTTC-3 '.
2) expression of Trx and preparation
The plasmid pETrx of step 1) is transformed BL21 (DE3) (purchasing in " TIANGEN Biotech (Beijing) Co., Ltd. "), on the LB substratum that contains kantlex (30ug/ml), cultivate, the screening transformant is BL21 (DE3)/pETrx.BL21 (DE3)/pETrx is cultured to OD in 37 ℃ in containing the LB substratum of kantlex
600Be 0.6; Adding isopropyl-makes its final concentration reach 0.4mM; 30 ℃ were continued wave and culture 4-5 hour; Then use the nickel-nitrilotriacetic acid affinity column purification of recombinant proteins (chromatography condition: wash post twice with 4-5ml Wash buffer, wash post with 0.5-1ml Elution buffer subsequently, collect all elutriants) of GE Healthcare (U.S.) company.Recombinant protein in the elutriant is carried out mass spectroscopy, be confirmed that it is the Trx shown in the aminoacid sequence among the sequence table SEQ ID No.1.Recombinant protein is analyzed the molecular weight consistent (referring to Fig. 1) of sequence in finding its molecular weight and showing SEQ ID No.1 with polyacrylamide gel electrophoresis (SDS-PAGE).
Above-mentioned Wash buffer composition is: 50mM NaH
2PO
4, 300mM NaCl, 20mM imidazole, pH 8.0; Above-mentioned Elution buffer composition is: 50mM NaH
2PO
4, 300mM NaCl, 250mMimidazole, pH 8.0.
The reductase activity of Trx
The Trx Trx of purifying is added A buffer (0.1M PBS, 2mM DTT, 2mMEDTA-Na
2, 1.25mg/ml insulin) to final concentration be 4uM.Control group adds isopyknic PBS.Measure light absorption value (A at 650nm behind 25 ℃ of insulation different times
650).The result shows, the A of control group
650Almost nil, and add the A that Trx organizes
650Value prolongs along with soaking time and significantly strengthens, and explains that Trx has tangible reductase activity (referring to Fig. 2).
Said PBS moity is by weight percentage: 0.8%NaCl, 0.02%KCl, 0.358%Na
2HPO
4.12H
2O, 0.024% NaH
2PO
4, surplus is a water.
Embodiment 4
The protection cell antioxygenation of Trx
Cynoglossus semilaevis head-kidney lymphocyte (is purchased the HyClone in Thermo Scientific, Beijing, the dull and stereotyped cultivation in 96-hole China) in containing the L-15 substratum.The extraction of head-kidney lymphocyte, cultural method are referring to reference Hu Y; Chen L; Sun L.CXCL8 of Scophthalmus maximus:expression, biological activity, and immunoregulatory effect.Dev Comp Immunol.2011; 35:1030-7.15ul Trx or PBS (contrast) are mixed 25 ℃ of insulation 0.5h with 15ul20mM DTT.It is 3ug/ml that Trx after the insulation is added lymphocyte to final concentration, adds H subsequently
2O
2To final concentration be 200uM.22 ℃ of insulation 1h, (China), 22 ℃ of insulation 4h add 200 μ ldimethyl sulfoxide, are measuring light absorption value (A at 490nm subsequently for Sangon, Shanghai to add 20 μ l5mg/ml MTT
490).The result shows, adds the A of the cell of Trx
490Be 3 times of control cells, explain that Trx can protect cell resistance H
2O
2Oxygenizement.
The promoting growth of cell effect of Trx
With Trx Trx or PBS (contrast) add as in the lymphocyte of above-mentioned embodiment 4 said cultivations to final concentration be 1.5ug/ml.Cell in 22 ℃ of insulations 2 days, is added 20 μ l 5mg/mlMTT, and 22 ℃ of insulation 4h add 200 μ l dimethyl sulfoxide, are measuring light absorption value (A at 490nm subsequently
490).The result shows, adds the A of the cell of Trx
490Be 2.5 times of control cells, explain that Trx can effectively promote cell proliferation.
In sum, Trx of the present invention has tangible reductase activity, antioxygenation and promoting growth of cell ability.
Claims (4)
1. Trx, it is characterized in that: Trx is shown in the aminoacid sequence among the sequence table SEQ ID No.1.
2. by the described Trx of claim 1, it is characterized in that: said Trx is the recombinant protein that contains the eukaryotic expression recombination plasmid pETrx transformed into escherichia coli DH5 α acquisition of tabulation SEQ ID No.1.
3. the preparation method of the described Trx of claim 1 is characterized in that:
With Cynoglossus semilaevis cDNA is template, carries out pcr amplification with primers F 1 with R1, is connected with carrier pBS-T behind the PCR product purification, connects the mixed solution transformed into escherichia coli, gets plasmid pBSTrx;
Above-mentioned plasmid pBSTrx and plasmid pET259 are cut with restriction enzyme EcoRV enzyme, and endonuclease bamhi connects with the T4DNA ligase enzyme, connects liquid and is transformed into intestinal bacteria, gets plasmid pETrx;
Above-mentioned gained plasmid pETrx is transformed BL21 (DE3), and gained transformant BL21 (DE3)/pETrx purifying gained recombinant protein is the Trx shown in the aminoacid sequence among the sequence table SEQ ID No.1;
Said F1 is 5 '-GATATCATGGTTTACGAAGTGAAAG-3 '; R1 is 5 '-GATATCTTCTTTTTCATACTGCTTC-3 '.
4. the application of the described Trx of claim 1 is characterized in that: the amino acid sequences encoded Trx among the said sequence table SEQ ID No.1 is as the preparation of reductase activity, anti-oxidant or promoting growth of cell.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210066091XA CN102586202A (en) | 2012-03-13 | 2012-03-13 | Thioredoxin and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210066091XA CN102586202A (en) | 2012-03-13 | 2012-03-13 | Thioredoxin and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102586202A true CN102586202A (en) | 2012-07-18 |
Family
ID=46475436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210066091XA Pending CN102586202A (en) | 2012-03-13 | 2012-03-13 | Thioredoxin and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102586202A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102875660A (en) * | 2012-09-11 | 2013-01-16 | 中国科学院海洋研究所 | Virus induced protein Mig1 and application thereof |
CN103232979A (en) * | 2013-05-21 | 2013-08-07 | 中国人民解放军第二军医大学 | Cyanea capillata thioredoxin and coding gene and application thereof |
CN107267475A (en) * | 2017-08-11 | 2017-10-20 | 浙江福斯特新材料研究院有限公司 | A kind of method that metal chelate affinity chromatography purifies thioredoxin |
CN114149983A (en) * | 2021-12-07 | 2022-03-08 | 中国林业科学研究院 | Thioredoxin for regulating and controlling identification of plant pollen tube and stigma and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1920570A (en) * | 2005-08-26 | 2007-02-28 | 中国科学院上海生命科学研究院 | Application of thioredoxin protein 2 |
CN101391100A (en) * | 2008-09-28 | 2009-03-25 | 中国人民解放军第四军医大学 | Use of recombined human source thioredoxin in preparing medicine for treating endotoxemia |
-
2012
- 2012-03-13 CN CN201210066091XA patent/CN102586202A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1920570A (en) * | 2005-08-26 | 2007-02-28 | 中国科学院上海生命科学研究院 | Application of thioredoxin protein 2 |
CN101391100A (en) * | 2008-09-28 | 2009-03-25 | 中国人民解放军第四军医大学 | Use of recombined human source thioredoxin in preparing medicine for treating endotoxemia |
Non-Patent Citations (1)
Title |
---|
SUN J. S. 等: "Cynoglossus semilaevis thioredoxin: a reductase and an antioxidant with immunostimulatory property", 《CELL STRESS AND CHAPERONES》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102875660A (en) * | 2012-09-11 | 2013-01-16 | 中国科学院海洋研究所 | Virus induced protein Mig1 and application thereof |
CN102875660B (en) * | 2012-09-11 | 2013-10-16 | 中国科学院海洋研究所 | Virus induced protein Mig1 and application thereof |
CN103232979A (en) * | 2013-05-21 | 2013-08-07 | 中国人民解放军第二军医大学 | Cyanea capillata thioredoxin and coding gene and application thereof |
CN107267475A (en) * | 2017-08-11 | 2017-10-20 | 浙江福斯特新材料研究院有限公司 | A kind of method that metal chelate affinity chromatography purifies thioredoxin |
CN114149983A (en) * | 2021-12-07 | 2022-03-08 | 中国林业科学研究院 | Thioredoxin for regulating and controlling identification of plant pollen tube and stigma and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rodríguez-Martín et al. | Characterization of the novel antifungal protein PgAFP and the encoding gene of Penicillium chrysogenum | |
CN110117323B (en) | Soluble human keratin and application thereof | |
CN102586202A (en) | Thioredoxin and preparation method and application thereof | |
PE20140867A1 (en) | AXMI-115, AXMI-113, AXMI-005, AXMI-163 AND AXMI-184: INSECTICIDE PROTEINS AND METHODS FOR THEIR USE | |
Huang et al. | Production of bioactive human beta-defensin 5 and 6 in Escherichia coli by soluble fusion expression | |
EA201170961A1 (en) | NEW BACILLUS THURINGIENSIS GENE WITH ACTIVITY AGAINST LEPIDOPTERA | |
BRPI0914780B8 (en) | ISOLATED NUCLEIC ACID MOLECULE, VECTOR, HOST CELL, COMPOSITION, AND METHODS FOR CONTROLLING A PEST POPULATION, KILLING A PEST PROTECTION OF A PLANT FROM A PEST AND PRODUCTION OF A POLYPEPTIDE WITH PESTICIDE ACTIVITY | |
Jiang et al. | Transcriptome analysis of venom glands from a single fishing spider Dolomedes mizhoanus | |
BR112015021651A2 (en) | RECOMBINANT NUCLEIC ACID MOLECULE, EXPRESSION CASSETTE, BACTERIAL HOST CELL, RECOMBINANT POLYPEPTIDE, COMPOSITION AND METHODS FOR APPLYING THEM | |
EA201690355A1 (en) | INSECTICIDAL POLYPEPTIDES WITH A WIDE SPECTRUM OF ACTIVITY AND THEIR APPLICATION | |
Chrzanowska-Lightowlers et al. | Human mitochondrial ribosomes can switch structural tRNAs–but when and why? | |
BR112018011896A2 (en) | promoter, nucleic acid, prokaryotic host cell, fermentation method, and method for enhancing catalase expression or activity in a prokaryotic host cell | |
US20190330280A1 (en) | Transcriptional regulatory fusion polypeptide | |
TW201617360A (en) | Methods and reagents for purification of proteins | |
CN109554414A (en) | Application of needle mushroom gene Fvegt1, Fvegt2 and the Fvegt3 in synthesis erythrothioneine | |
CN103849613A (en) | Thermal stability improved mutant enzyme of D-psicose 3-epimerase and application thereof | |
BRPI0410562B8 (en) | carrier protein and its production method in a plant, isolated nucleic acid, expression vector and host cell | |
Sun et al. | High level expression and purification of active recombinant human interleukin-15 in Pichia pastoris | |
US11548926B2 (en) | Method for producing an active hepatocyte growth factor (HGF) | |
UA122856C2 (en) | VARIANT INSECTICIDE GENE AHMI115 AND METHODS OF ITS APPLICATION | |
CN102942624B (en) | Galectin-3 binding protein, preparation and application thereof | |
CN102241759B (en) | Bacteriostatic ferritin and preparation and application thereof | |
RU2012141653A (en) | METHOD FOR PRODUCING SOLUBLE RECOMBINANT PROTEIN INTERFERON WITHOUT DENATURING | |
CN102675445A (en) | Ubiquitin-like modified protein, preparation and application thereof | |
Zhu et al. | A novel ribonuclease with HIV-1 reverse transcriptase inhibitory activity from the edible mushroom Hygrophorus russula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120718 |